A. Gregor
- Genetics top 1%
- Glioma Diagnosis and Treatment 20
-
- Lung Cancer Treatments and Mutations 18
- Brain Metastases and Treatment 13
- Lung Cancer Diagnosis and Treatment 13
- Oncology top 2%
- Lung Cancer Research Studies 22
- Radiation top 5%
- Otorhinolaryngology top 5%
-
- Neuroendocrine Tumor Research Advances 11
-
- Cancer therapeutics and mechanisms 7
-
- Management of metastatic bone disease 7
- Co-authors
- A. CullFergus MacbethG.R. KerrR. StoutP RocmansM Turner‐WarwickRJ StephensJean‐Pierre Pignon
- Partner nations
- United KingdomUnited StatesBelgium
In The Last Decade
A. Gregor
62 papers receiving 2.4k citations
Hit Papers
Peers
Comparison fields: 5 of 106
- Genetics 600
- Pulmonary and Respiratory Medicine 1.8k
- Oncology 989
- Radiation 170
- Otorhinolaryngology 84
Countries citing papers authored by A. Gregor
This map shows the geographic impact of A. Gregor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Gregor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Gregor more than expected).
Fields of papers citing papers by A. Gregor
This network shows the impact of papers produced by A. Gregor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Gregor. The network helps show where A. Gregor may publish in the future.
Co-authorship network
The 25 scholars most cited alongside A. Gregor, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 12 | |
| 2 | 2004 | 69 | |
| 3 | 2003 | 44 | |
| 4 | 2003 | 52 | |
| 5 | 2001 | 109 | |
| 6 | 2000 | 21 | |
| 7 | Medical Research Council (MRC) randomised trial of adjuvant chemotherapy in primary CNS lymphoma (PCL)- BR06. | 1998 | 1 |
| 8 | 1998 | 20 | |
| 9 | 1997 | 260 | |
| 10 | Referral pattern and management of patients with malignant brain tumours in south east Scotland. | 1996 | 8 |
| 11 | 1996 | 104 | |
| 12 | 1995 | 5 | |
| 13 | 1995 | 8 | |
| 14 | 1994 | 60 | |
| 15 | 1994 | 10 | |
| 16 | 1994 | 1 | |
| 17 | 1993 | 40 | |
| 18 | 1991 | 10 | |
| 19 | 1990 | 18 | |
| 20 | 1988 | 26 |
About A. Gregor
A. Gregor is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Oncology, having authored 64 papers that have together received 2.5k indexed citations. Recurring topics across this work include Lung Cancer Research Studies (22 papers), Glioma Diagnosis and Treatment (20 papers), Lung Cancer Treatments and Mutations (18 papers), Brain Metastases and Treatment (13 papers), Lung Cancer Diagnosis and Treatment (13 papers), Neuroendocrine Tumor Research Advances (11 papers), Cancer therapeutics and mechanisms (7 papers) and Management of metastatic bone disease (7 papers). The work is most often cited by research in Genetics (600 citations), Pulmonary and Respiratory Medicine (1.8k citations) and Oncology (989 citations). A. Gregor has collaborated with scholars based in United Kingdom, United States and Belgium. Frequent co-authors include A. Cull, Fergus Macbeth, G.R. Kerr, R. Stout, P Rocmans, M Turner‐Warwick, RJ Stephens, Jean‐Pierre Pignon, DJ Girling and M Debevec. Their work appears in journals such as Lung Cancer, European Journal of Cancer, Clinical Oncology, Thorax and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.